Singapore, May 2 -- US-based RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, has announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science.

This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the potential to revolutionise the treatment of degenerative disease.

Uniting RoosterBio's extensive portfolio of hMSC-based products and processes withThermo Fisher'sadvanced therapy GMP contract manufacturing capabilities, customers can access a new comprehensive solution for the development and manufacturing of hMSC and exosome ther...